Update on pertussis in children

References

• Shrivastava R, Miller JF. Virulence factor secretion and translocation by Bordetella species. Curr. Opin. Microbiol.12, 88–93 (2009).
   PubMedGoogle Scholar
• Crowcroft NS, Booy R, Harrison T et al. Severe and unrecognised: pertussis in UK infants. Arch. Dis. Child.88, 802–806 (2003).
   PubMed Web of Science ®Google Scholar
• Bisgard KM, Pascual FB, Ehresmann KR et al. Infant pertussis: who was the source? Pediatr. Infect. Dis. J.23, 985–989 (2004).
   PubMed Web of Science ®Google Scholar
• Bonmarin I, Levy-Bruhl D, Baron S et al. Pertussis surveillance in French hospitals: results from a 10 year period. Euro. Surveill.12, 1–8 (2007).
   Google Scholar
• Kowalzik F, Barbosa AP, Fernandes VR et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr. Infect. Dis. J.26, 238–242 (2007).
   PubMed Web of Science ®Google Scholar
• Wendelboe AM, Njamkepo E, Bourillon A et al. Transmission of Bordetella pertussis to young infants. Pediatr. Infect. Dis. J.26, 293–299 (2007).
   PubMed Web of Science ®Google Scholar
• Robert Koch-Institut: Impfempfehlungen der Ständigen Impfkommission am Robert Koch-Institut/Stand Juli 2009. Epidemiol. Bull.30, 279–298 (2009).
   Google Scholar
• Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine25, 2634–2642 (2007).
   PubMed Web of Science ®Google Scholar
• Heininger U, Stehr K, Schmitt-Grohé S et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr. Infect. Dis. J.13, 306–309 (1994).
   PubMed Web of Science ®Google Scholar
• Stefanelli P, Mastrantonio P, Hausman SZ, Giuliano M, Burns DL. Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs. J. Clin. Microbiol.35, 1550–1555 (1997).
   PubMedGoogle Scholar
• Mazengia E, Silva EA, Peppe JA, Timperi R, George H. Recovery of Bordetella holmesii from patients with pertussis-like symptoms: use of pulsed-field gel electrophoresis to characterize circulating strains. J. Clin. Microbiol.38, 2330–2333 (2000).
   PubMed Web of Science ®Google Scholar
• Weyant RS, Hollis DG, Weaver RE et al.Bordetella holmesii sp. nov., a new Gram-negative species associated with septicemia. J. Clin. Microbiol.33, 1–7 (1995).
   PubMed Web of Science ®Google Scholar
• Spilker T, Liwienski AA, LiPuma JJ. Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis. Clin. Microbiol. Infect.14, 504–506 (2008).
   PubMedGoogle Scholar
• Daxboeck F, Goerzer E, Apfalter P, Nehr M, Krause R. Isolation of Bordetella trematum from a diabetic leg ulcer. Diabet. Med.21, 1247–1248 (2004).
   PubMedGoogle Scholar
• Vandamme P, Heyndrickx M, Vancanneyt M et al.Bordetella trematum sp. nov., isolated from wounds and ear infections in humans, and reassessment of Alcaligenes denitrificans Rüger and Tan 1983. Int. J. System. Bacteriol.46, 849–858 (1996).
   PubMedGoogle Scholar
• Stark D, Riley LA, Harkness J, Marriott D. Bordetella petrii from a clinical sample in Australia: isolation and molecular identification. J. Med. Microbiol.56, 435–437 (2007).
   PubMedGoogle Scholar
• Cherry JD, Heininger U. Pertussis and other Bordetella infections. In: Textbook of Pediatric Infectious Diseases (6th Edition). Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds). WB Saunders, PA, USA, 1683–1706 (2009).
   Google Scholar
• Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev.18, 326–382 (2005).
   PubMed Web of Science ®Google Scholar
• Heininger U, Cherry JD, Eckhardt T, Lorenz C, Christenson P, Stehr K. Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany. Pediatr. Infect. Dis. J.12, 504–509 (1993).
   PubMed Web of Science ®Google Scholar
• Waters V, Jamieson F, Richardson SE, Finkelstein M, Wormsbecker A, Halperin SA. Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children. Pediatr. Infect. Dis. J.28, 582–587 (2009).
   PubMedGoogle Scholar
• Narkeviciute I, Kavaliunaite E, Bernatoniene G, Eidukevicius R. Clinical presentation of pertussis in fully immunized children in Lithuania. BMC Infect. Dis.5, 40 (2005).
   PubMedGoogle Scholar
• Long S, Lischner H, Deforest A, Clark J. Serologic evidence of subclinical pertussis in immunized children. Pediatr. Infect. Dis. J.9, 700–705 (1990).
   PubMed Web of Science ®Google Scholar
• Edelman K, Nikkari S, Ruuskanen O, He Q, Viljanen M, Mertsola J. Detection of Bordetella pertussis by polymerase chain reaction and culture in the nasopharynx of erythromycin-treated infants with pertussis. Pediatr. Infect. Dis. J.15, 54–57 (1996).
   PubMedGoogle Scholar
• Cherry JD, Brunell PA, Golden GS, Karzon DT. Report of the task force on pertussis and pertussis immunization – 1988. Pediatrics.81(Suppl.), 939–984 (1988).
   Google Scholar
• Heininger U, Klich K, Stehr K, Cherry JD. Clinical findings in Bordetella pertussis infections: results of a prospective multicenter surveillance study. Pediatrics100(6), E10 (1997).
   PubMedGoogle Scholar
• Halasa NB, Barr FE, Johnson JE, Edwards KM. Fatal pulmonary hypertension associated with pertussis in infants: does extracorporal membrane oxygenation have a role? Pediatrics112, 1274–1278 (2003).
   PubMed Web of Science ®Google Scholar
• Surridge J, Segedin ER, Grant CC. Pertussis requiring intensive care. Arch. Dis. Child.92, 970–975 (2007).
   PubMed Web of Science ®Google Scholar
• Heininger U, Stehr K, Schmidt-Schläpfer G et al.Bordetella pertussis infections and sudden unexpected deaths in children. Eur. J. Pediatr.155, 551–553 (1996).
   PubMedGoogle Scholar
• Lindgren C, Milerad J, Lagercrantz H. Sudden infant death and prevalence of whooping cough in the Swedish and Norwegian communities. Eur. J. Pediatr.156, 405–409 (1997).
   PubMedGoogle Scholar
• Crowcroft NS, Andrews N, Rooney C, Brisson M, Miller E. Deaths from pertussis are underestimated in England. Arch. Dis. Child.86, 336–338 (2002).
   PubMed Web of Science ®Google Scholar
• Wood N, McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr. Respir. Rev.9, 201–211 (2008).
   PubMed Web of Science ®Google Scholar
• Wirsing von König CH, Rott H, Bogaerts H, Schmitt HJ. A serologic study of organisms possibly associated with pertussis-like coughing. Pediatr. Infect. Dis. J.17, 645–649 (1998).
   PubMedGoogle Scholar
• Edelman K, Nikkari S, Ruuskanen O, He Q, Viljanen M, Mertsola J. Detection of Bordetella pertussis by polymerase chain reaction and culture in the nasopharynx of erythromycin-treated infants with pertussis. Pediatr. Infect. Dis. J.15, 54–57 (1996).
   PubMedGoogle Scholar
• Heininger U, Frei R, Cherry JD, Stehr K. Comparison of pulsed field gel electrophoresis patterns of Bordetella pertussis isolates from unvaccinated children with severe or mild pertussis. Pediatr. Infect. Dis. J.23, 211–217 (2004).
   PubMedGoogle Scholar
• Bartkus JM, Juni BA, Ehresmann K et al. Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance. J. Clin. Microbiol.41, 1167–1172 (2003).
   PubMed Web of Science ®Google Scholar
• Fry NK, Duncan J, Wagner K et al. Role of PCR in the diagnosis of pertussis infection in infants: 5 years’ experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007. J. Med. Microbiol.58, 1023–1029 (2009).
   PubMed Web of Science ®Google Scholar
• Heininger U, Schmidt-Schläpfer G, Cherry JD, Stehr K. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics105(3), E31 (2000).
   PubMed Web of Science ®Google Scholar
• Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr. Infect. Dis. J.24, S25–S34 (2005).
   PubMedGoogle Scholar
• Meade BD, Bollen A. Recommendations for use of the polymerase chain reaction in the diagnosis of Bordetella pertussisinfections. J. Med. Microbiol.41, 51–55 (1994).
   PubMed Web of Science ®Google Scholar
• Baughman AL, Bisgard KM, Edwards KM et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin. Diagn. Lab. Immunol.11, 1045–1053 (2004).
   PubMedGoogle Scholar
• Bonhoeffer J, Bar G, Riffelmann M, Soler M, Heininger U. The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis. Infection33, 13–7 (2005).
   PubMed Web of Science ®Google Scholar
• Wirsing von König CH, Gounis D, Laukamp S, Bogaerts H, Schmitt HJ. Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children. Eur. J. Clin. Microbiol. Infect. Dis.18, 341–345 (1999).
   PubMedGoogle Scholar
• Romano MJ, Weber MD, Weisse ME, Siu BL. Pertussis pneumonia, hypoxemia, hyperleukocytosis, and pulmonary hypertension: improvement in oxygenation after a double volume exchange transfusion. Pediatrics114, e264–e266 (2004).
   PubMed Web of Science ®Google Scholar
• Sawal M, Cohen M, Irazuzta JE et al. Fulminant pertussis: a multi-center study with new insights into the clinico-pathological mechanisms. Pediatr. Pulmonol.44, 970–980 (2009).
   PubMed Web of Science ®Google Scholar
• Zoumboulakis D, Anagnostakis D, Albanis V, Matsaniotis. Steroids in treatment of pertussis – a controlled clinical trial. Arch. Dis. Child.48, 51–54 (1973).
   PubMedGoogle Scholar
• Tam AY, Yeung CY. Severe neonatal pertussis treated by salbutamol. Arch. Dis. Child.61, 600–602 (1986).
   PubMedGoogle Scholar
• Hoppe JE. State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis. Infection26, 242–246 (1998).
   PubMed Web of Science ®Google Scholar
• Korgenski EK, Daly JA. Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the Intermountain West region of the United States. J. Clin. Microbiol.35, 2989–2991 (1997).
   PubMed Web of Science ®Google Scholar
• Aoyama T, Sunakawa K, Iwata S, Takeuchi Y, Fujii R. Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. J. Pediatr.129, 761–764 (1996).
   PubMedGoogle Scholar
• Langley JM, Halperin SA, Boucher FD, Smith B, Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC). Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics114, e96–e101 (2004).
   PubMed Web of Science ®Google Scholar
• Lebel MH, Mehra F, Mehra S. Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial. Pediatr. Infect. Dis. J.20, 1149–1154 (2001).
   PubMedGoogle Scholar
• Hoppe JE and the Erythromycin Study Group. Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of pertussis. Pediatr. Infect. Dis. J.11, 189–193 (1992).
   PubMed Web of Science ®Google Scholar
• Bass JW, Harden LB. Treatment and prophylaxis failure of erythromyin in pertussis. Am. J. Dis. Child.134, 1178–1179 (1980).
   PubMedGoogle Scholar
• Halperin SA, Bortolussi R, Langley JM, Miller B, Eastwood BJ. Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. Pediatrics100, 65–71 (1997).
   PubMed Web of Science ®Google Scholar
• Aoyama T, Sunakawa K, Iwata S, Takeuchi Y, Fujii R. Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. J. Pediatr.129, 761–764 (1996).
   PubMedGoogle Scholar
• Centers for Disease Control. Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin – Knoxville, Tennessee, 1999. MMWR48, 1117–1120 (1999).
   PubMedGoogle Scholar
• Honein MA, Paulozzi LJ, Himelright IM et al. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study. Lancet354, 2101–2105 (1999).
   PubMed Web of Science ®Google Scholar
• Morrison W. Infantile hypertrophic pyloric stenosis in infants treated with azithromycin. Pediatr. Infect. Dis. J.26, 186–188 (2007).
   PubMed Web of Science ®Google Scholar
• Hoppe J, Halm U, Hagedorn H, Kraminer-Hagedorn A. Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis. Infection17, 227–231 (1989).
   PubMedGoogle Scholar
• Dodhia H, Crowcroft NS, Bramley JC, Miller E. UK guidelines for use of erythromycin chemoprophylaxis in persons exposed to pertussis. J. Public Health Med.24, 200–206 (2002).
   PubMedGoogle Scholar
• De Serres G, Boulianne N, Duval B. Field effectiveness of erythromycin prophylaxis to prevent pertussis within families. Pediatr. Infect. Dis. J.14, 969–975 (1995).
   PubMedGoogle Scholar
• Halperin SA, Bortolussi R, Langley JM, Eastwood BJ, De Serres G. A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive Bordetella pertussis infection. Pediatrics104(4), e42 (1999).
   PubMedGoogle Scholar
• Crameri S, Heininger U. Successful control of a pertussis outbreak in a university children’s hospital. Int. J. Infect. Dis.12, e85–e87 (2008).
   PubMed Web of Science ®Google Scholar
• Tozzi AE, Pandolfi E, Celentano LP et al. Comparison of pertussis surveillance systems in Europe. Vaccine25, 291–297(2007).
   PubMed Web of Science ®Google Scholar
• Ward JI, Cherry JD, Chang SJ et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N. Engl. J. Med.353, 1555–1563 (2005).
   PubMed Web of Science ®Google Scholar
• Long S, Welkon C, Clark J. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J. Infect. Dis.161, 480–486 (1990).
   PubMed Web of Science ®Google Scholar
• Anderson RM, May RM. Immunisation and herd immunity. Lancet335(8690), 641–645 (1990).
   PubMed Web of Science ®Google Scholar
• Forsyth KD, Campins-Marti M, Caro J et al. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. Clin. Infect. Dis.39, 1802–1809 (2004).
   PubMed Web of Science ®Google Scholar
• Cherry JD, Baraff LJ, Hewlett E. The past, present, and future of pertussis. The role of adults in epidemiology and future control. West. J. Med.150, 319–328 (1989).
   PubMedGoogle Scholar
• Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr. Infect. Dis. J.24, S25–S34 (2005).
   PubMedGoogle Scholar
• Pebody RG, Gay NJ, Giammanco A et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol. Infect.133, 159–171 (2005).
   PubMed Web of Science ®Google Scholar
• Rota MC, D’Ancona F, Massari M et al. How increased pertussis vaccination coverage is changing the epidemiology of pertussis in Italy. Vaccine23, 5299–5305 (2005).
   PubMedGoogle Scholar
• Hellenbrand W, Beier D, Jensen E et al. The epidemiology of pertussis in Germany: past and present. BMC Infect. Dis.25, 22 (2009).
   Google Scholar
• Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin. Infect. Dis.28(Suppl. 2), S112–S117 (1999).
   PubMed Web of Science ®Google Scholar
• Hennes H. Der Keuchhusten bei Erwachsenen. Med. Klinik.17, 591–593 (1921).
   Google Scholar
• Nelson JD. The changing epidemiology of pertussis in young infants: the role of adults as reservoirs of infection. Am. J. Dis. Child.132, 371–373 (1978).
   PubMedGoogle Scholar
• Mortimer EA. Pertussis and its prevention: a family affair. J. Infect. Dis.161, 473–479 (1990).
   PubMed Web of Science ®Google Scholar
• Heininger U, Stehr K, Christenson P, Cherry JD. Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection. Clin. Infect. Dis.28, 602–604 (1999).
   PubMedGoogle Scholar
• Trollfors B, Taranger J, Lagergard T et al. A placebo-controlled trial of a pertussis-toxoid vaccine. N. Engl. J. Med.333, 1045–1050 (1995).
   PubMed Web of Science ®Google Scholar
• Greco D, Salmaso S, Mastrantonio P et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med.334, 341–348 (1996).
   PubMed Web of Science ®Google Scholar
• Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular and a whole-cell pertussis vaccine. N. Engl. J. Med.334, 349–355 (1996).
   PubMed Web of Science ®Google Scholar
• Schmitt HJ, Wirsing von König CH, Neiss A et al. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA.275, 37–41 (1996).
   PubMed Web of Science ®Google Scholar
• Simondon F, Preziosi MP, Yam A et al. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine15, 1606–1612 (1997).
   PubMed Web of Science ®Google Scholar
• Liese JG, Meschievitz CK, Harzer E et al. Efficacy of a two-component acellular pertussis vaccine in infants. Pediatr. Infect. Dis. J.16, 1038–1044 (1997).
   PubMed Web of Science ®Google Scholar
• Stehr K, Cherry JD, Heininger U et al. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine or DT vaccine. Pediatrics101, 1–11 (1998).
   PubMed Web of Science ®Google Scholar
• Heininger U, Cherry JD. Pertussis immunisation in adolescents and adults – Bordetella pertussis epidemiology should guide vaccination recommendations. Expert. Opin. Biol. Ther.6, 685–697 (2006).
   PubMedGoogle Scholar
• Collins CL, Salt P, McCarthy N et al. Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children. Vaccine22, 4262–4269 (2004).
   PubMed Web of Science ®Google Scholar
• Minh NN, He Q, Ramalho A et al. Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents. Pediatrics104, e70 (1999).
   PubMedGoogle Scholar
• Cherry JD. ‘Pertussis vaccine encephalopathy’: it is time to recognize it as the myth that it is. JAMA263, 1679–1680 (1990).
   PubMedGoogle Scholar
• Heininger U, Zuberbühler M. Immunization rates and timely administration in pre-school and school-aged children. Eur. J. Pediatr.165, 124–129 (2006).
   PubMedGoogle Scholar
• Elomaa A, He Q, Minh NN, Mertsola J. Pertussis before and after the introduction of acellular pertussis vaccines in Finland. Vaccine27, 5443–5449 (2009).
   PubMed Web of Science ®Google Scholar
• Juretzko P, von Kries R, Hermann M, Wirsing von König CH, Weil J, Giani G. Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany. Clin. Infect. Dis.35, 162–167 (2002).
   PubMedGoogle Scholar
• Heininger U, Cherry JD, Stehr K et al. Comparative efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP). vaccine and Lederle whole-cell component DTP vaccine in German infants following household exposure. Pediatrics102, 546–553 (1998).
   PubMed Web of Science ®Google Scholar
• Halasa NB, O’Shea A, Shi JR, LaFleur BJ, Edwards KM. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J. Pediatr.153, 327–332 (2008).
   PubMed Web of Science ®Google Scholar
• Knuf M, Schmitt HJ, Wolter J et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J. Pediatr.152, 655–660 (2008).
   PubMed Web of Science ®Google Scholar
• Heininger U, Cherry JD, Christenson P et al. Comparative study of Lederle/Takeda acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants in Germany. Vaccine12, 81–86 (1994).
   PubMedGoogle Scholar
• Van Rie A, Wendelboe AM, Englund JA. Role of maternal pertussis antibodies in infants. Pediatr. Infect. Dis. J.24(Suppl.), S62–S65 (2005).
   PubMedGoogle Scholar
• de La Rocque F, Grimprel E, Gaudelus J et al. Vaccination in parents of young infants survey. Arch. Pediatr.14, 1472–1476 (2007).
   PubMedGoogle Scholar